Escape from the host erythrocyte by the invasive stage of the malaria parasite Plasmodium falciparum is a fundamental step in the pathogenesis of malaria of which little is known. Upon merozoite invasion of the host cell, the parasite becomes enclosed within a parasitophorous vacuole, the compartment in which the parasite undergoes growth followed by asexual division to produce 16-32 daughter merozoites. These daughter cells are released upon parasitophorous vacuole and erythrocyte membrane rupture. To examine the process of merozoite release we have used P.falciparum lines expressing GFP-chimeric proteins targeted to the compartments from which merozoites must exit; the parasitophorous vacuole and the host erythrocyte cytosol. This allowed visualization of merozoite release in live parasites. Here we provide the first evidence in live untreated cells that merozoite release involves a primary rupture of the parasitophorous vacuole membrane followed by a secondary rupture of the erythrocyte plasma membrane. We have confirmed that parasitophorous vacuole membrane rupture occurs prior to erythrocyte plasma membrane rupture in untransfected wild-type parasites using immunoelectron microscopy. We have also demonstrated selective inhibition of each step in this two-step process of exit using different protease inhibitors, implicating the involvement of distinct proteases in each of these steps. This will facilitate the identification of the parasite and host molecules involved in merozoite release.
SUMMARY
Escape from the host erythrocyte by the invasive stage of the malaria parasite Plasmodium falciparum is a fundamental step in the pathogenesis of malaria of which little is known. Upon merozoite invasion of the host cell, the parasite becomes enclosed within a parasitophorous vacuole, the compartment in which the parasite undergoes growth followed by asexual division to produce [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] daughter merozoites. These daughter cells are released upon parasitophorous vacuole and erythrocyte membrane rupture. To examine the process of merozoite release we have used P.falciparum lines expressing GFP-chimeric proteins targeted to the compartments from which merozoites must exit; the parasitophorous vacuole and the host erythrocyte cytosol. This allowed visualization of merozoite release in live parasites. Here we provide the first evidence in live untreated cells that merozoite release involves a primary rupture of the parasitophorous vacuole membrane followed by a secondary rupture of the erythrocyte plasma membrane. We have confirmed that parasitophorous vacuole membrane rupture occurs prior to erythrocyte plasma membrane rupture in untransfected wild-type parasites using immunoelectron microscopy. We have also demonstrated selective inhibition of each step in this two-step process of exit using different protease inhibitors, implicating the involvement of distinct proteases in each of these steps. This will facilitate the identification of the parasite and host molecules involved in merozoite release. 
INTRODUCTION
During the erythrocytic phase of the P.falciparum lifecycle, the merozoites released initially from infected hepatocytes attach to and invade human erythrocytes in the bloodstream. Upon invasion of the host cell, the parasites become enclosed in a parasitophorous vacuole in which, as ring and trophozoite stages, they undergo growth followed by asexual division (schizogony) to produce 16-32 daughter merozoites. It is from both this vacuole and the host erythrocyte that the newly formed merozoites in the schizont must escape.
While little is known about the molecules that mediate this process, proteases have been implicated in both parasite exit from the erythrocyte and the subsequent invasion into erythrocytes through the use of protease inhibitors that halt these processes (1) (2) (3) . Following the demonstration that P. knowlesi schizonts incubated in the presence of the protease inhibitors chymostatin and leupeptin show decreased reinvasion due to inhibition of schizont maturation (3, 4) , Lyon and Haynes demonstrated that P.falciparum schizonts cultured in the presence of the inhibitors chymostatin, leupeptin, antipain and pepstatin also fail to rupture properly (2) . Recently it has been demonstrated that the protease inhibitors E-64 and E-64d inhibit schizont maturation (5, 6) . The role of the proteases involved in schizont rupture is presumably to degrade both the parasitophorous vacuole and the erythrocyte membrane skeleton, thereby facilitating release. However, the proteases involved have not yet been fully characterized. A number of inhibitor-sensitive parasite proteases have been implicated in schizont rupture, including the aspartic protease plasmepsin II which has been demonstrated to digest spectrin, actin and protein 4.1 at neutral by guest on October 5, 2017 http://www.jbc.org/ Downloaded from pH (7), falcipain-2; a cysteine protease that cleaves erythrocyte ankyrin and protein 4.1 (8) (9) (10) (11) , and the cysteine protease-like SERA (serine repeat antigen) family, the members of which possess a centrally located papain-like protease domain (1, (12) (13) (14) . Interestingly, inhibition of the proteolytic processing of SERA is possible using protease inhibitors that block schizont rupture (15) . The relevance of these protease activities to the process of merozoite release remains to be determined, and the availability of the genome sequence of P.falciparum has facilitated the identification of further protease-like molecules that may play a role (12, 16) .
Ultrastructural evidence suggests that during schizogony the parasite plasma membrane invaginates to surround the merozoites forming within the confines of the parasitophorous vacuole (17) , and that late in schizogony, the parasitophorous vacuole membrane may be absent with the fully formed merozoites free within the host erythrocyte (17, 18) . This suggests that escape from the parasitophorous vacuole occurs prior to exit from the erythrocyte, but this possibility remains uninvestigated. An alternate model for schizont rupture has been proposed which involves escape from the host erythrocyte of the merozoites enclosed within the parasitophorous vacuole, followed by extraerythrocytic rupture of the vacuole and release of invasive merozoites
Here we examine the mechanism of parasite exit from the host erythrocyte in both wild-type and transgenic P.falciparum lines. Presented here is the first evidence in live untreated cells that rupture of the parasitophorous vacuole membrane occurs while the parasite is within the erythrocyte (Figure 1 B) To generate transgenic Plasmodium falciparum-infected erythrocytes expressing KAHRP-GFP chimeric proteins we made transfection constructs in the plasmid vector pHH2 (19, 20) as described (21) . A region of the KAHRP gene encoding the first 60 amino acids, which includes a putative hydrophobic signal sequence of eleven amino acids, was joined upstream of the GFP coding sequence in the transfection vector pHH2 (20) . Parasites stably transfected with this construct traffic the GFP fusion into the parasitophorous vacuole throughout the asexual lifecycle (21) . These parasites are designated 3D7-His. A region of the KAHRP gene encoding the first 123 amino acids of KAHRP was joined upstream of the GFP coding sequence. This region of KAHRP contains both the putative hydrophobic signal sequence required for transit to the parasitophorous vacuole, and the histidine rich region that contains the signal required for translocation into the erythrocyte (21) . Transgenic parasites expressing this construct traffic the GFP fusion into the erythrocyte cytosol throughout the asexual lifecycle. These parasites are designated 3D7+His. The 3D7 cloned P.falciparum parasites were transfected by electroporation and drug selected using 0.25 nM WR99210 as previously described (22) .
Fractionation of infected erythrocytes and western blotting.
For permeablisation of infected red cells with streptolysin-O (SLO), haemolytic activity of SLO was determined and 2x10 7 parasites were incubated in RPMI containing 3-4 haemolytic units of SLO as described (23, 24 
Protease Inhibitor Treatment.
Parasitised cells were synchronised by two consecutive sorbitol treatments 4 hr apart, cultured until middle-stage schizonts, then treated with 10 mM of Ltransepoxy-succinyl-leucylamido-(4-guanidino)butane (E-64) (Sigma) as described (5) or a combination of 10 mg/ml each of leupeptin and antipain, or leupeptin and chymostatin (Sigma) as described (2) .
Indirect Immunofluorescence Assay.
Indirect immunofluorescence assays were performed on control and protease 
Fluorescence Microscopy.
Ring stage parasites were synchronised using two consecutive sorbitol treatments 4 hours apart, cultured until early stage schizonts, and samples taken hourly during the process of schizongony and merozoite release.
Protease inhibitor treated and control parasites were cultured in DAPI at final concentration of 2 mg/ml for 30 min at 37ºC immediately prior to imaging. In 3D7+His parasites, the GFP fusion was observed both in the erythrocyte cytosol, the compartment to which it is targeted, and immediately surrounding the fully formed merozoites (Figure 2 C, black arrow). However, in early schizonts the GFP fusion is excluded from the vacuole surrounding the merozoites. This again supports an intraerythrocytic rupture of the vacuolar membrane, allowing diffusion of GFP from the erythrocyte to surround the merozoites.
Fractionation of GFP-expressing parasites
To examine this intraerythrocytic rupture of the vacuolar membrane at a population level, cell fractionation using saponin and streptolysin O was utilized. Saponin fractionation allows analysis of the export of proteins from the parasite as it lyses both the erythrocyte plasma and parasitophorous vacuole membranes, leaving the parasite plasma membrane intact. Upon fractionation with saponin, proteins retained within the parasite will be present in the pellet and those exported from the parasite will be detected in the supernatant. Intraerythrocytic parasitophorous vacuole rupture in wild-type parasites.
To confirm that parasitophorous vacuole rupture occurs within the erythrocyte in wild-type parasites, immuno-electron microscopy using antibodies to SAntigen, a P.falciparum protein that localizes to the parasitophorous vacuole 
Determination of Membrane Origin
To determine both the origin of the limiting membrane of incompletely 
DISCUSSION
These data provide the first direct evidence that P.falciparum merozoites escape from the host erythrocyte is a two-step process involving a primary exit from the vacuole it acquires upon entry, followed by a secondary exit from the erythrocyte itself (Figure 1 B) .
It has been shown ultrastructurally that early in schizogony the parasite plasma membrane invaginates to surround the merozoites forming within the confines of the parasitophorous vacuole (17) . Late in schizogony the parasitophorous This sequence of events clearly occurs at the population level, as detected by the release of parasitophorous vacuolar contents into the host erythrocyte cytosol.
Both steps in this two-step process can be selectively inhibited; the primary vacuolar lysis by E-64 and the secondary erythrocyte membrane rupture by leupeptin and antipain, indicating that independent proteases mediate each step. Since E-64 is an irreversible inhibitor of cysteine proteases that does not inhibit serine proteases, it is likely that the protease(s) involved in parasitophorous vacuole lysis is a cysteine protease. The components of the parasitophorous vacuole that such a protease(s) would proteolytically process remain to be identified. The protease inhibitors shown to inhibit erythrocyte plasma membrane rupture are leupeptin, antipain, chymostatin and pepstatin (2, 3, 30) . Leupeptin and antipain, used in this study at 10 mg/ml, each inhibit both trypsin-like serine proteases and cysteine proteases. Pepstatin is a nonselective inhibitor of aspartic proteases, and chymostatin inhibits both serine proteases and cysteine proteases -both of these inhibit schizont maturation at 10 mg/ml (2). It is therefore possible that the protease(s) mediating erythrocyte plasma membrane rupture is a cysteine or serine protease. However, it is likely that the rupture of each membrane involves a cascade of events that may be inhibited at different points using inhibitors with different specificities. As such it remains possible that erythrocyte plasma membrane rupture involves both an aspartic protease and a cysteine or serine protease.
It is important to note that E-64, which inhibits parasitophorous vacuolar lysis, appears to do so only when added to middle stage schizonts (15) -no inhibition is observed with late stage schizonts (5). One explanation for this lack of inhibition of vacuolar rupture in late stage schizonts is that the parasitophorous vacuole membrane degradation has already commenced in these parasites.
That leupeptin and antipain do not inhibit parasitophorous vacuole rupture may suggest that these inhibitors do not access the parasitophorous vacuole of infected erythrocytes. However, it has been demonstrated that leupeptin added to parasite cultures inhibits the processing of SERA, which localises to the parasitophorous vacuole, from a 56 kDa fragment to a 50 kDa fragment (15) , indicating that leupeptin is indeed able to access the parasitophorous vacuole of P.falciparum infected erythrocytes. Additionally, the more membrane permeable analogue of E-64, E-64d, that lacks charged groups, has been demonstrated to block schizont development (6) again suggesting that the site of action of these inhibitors does not result from permeability differences.
The inhibitor-sensitive proteases identified so far which may be involved in It is possible that degradation of the parasitophorous vacuole membrane is required for these proteases to gain access to their substrates at the erythrocyte plasma membrane, but the degradation of the erythrocyte plasma membrane in the presence of E-64 suggests that the proteases responsible may be actively trafficked across the vacuolar membrane.
The identification of the molecules mediating the process of schizont rupture is complicated by correlating inhibitor studies based on cell-free assays with experiments on P.falciparum parasite culture. For instance, leupeptin inhibits schizont rupture at concentrations of up to 68 mg/ml (15) through the inhibition of erythrocyte plasma membrane rupture (2) . At higher concentrations (678 mg/ml), leupeptin inhibits both the proteolytic processing of SERA in cell-free assays (15) , and the cleavage of ankyrin by falcipain-2 (9) . Likewise E-64, which clearly inhibits parasitophorous vacuolar rupture at 10 mM (5), also inhibits SERA and ankyrin cleavage at higher concentrations (100 mM and 10-100 mM, respectively) (9, 15) . Consequently, the roles of these candidate protease activites in the process of escape remain to be elucidated.
There has already been some success in the design of inhibitors selective for the aspartic proteases plasmepsin I and II (35) (36) (37) and the papain-family cysteine proteases known as the falcipains (6, 11, (38) (39) (40) (41) (42) . 
